The renin-angiotensin system and atherosclerosis

Area of Science:

• Cardiovascular Science
• Vascular Biology
• Medical Research

Background:

• Atherosclerosis is a complex arterial disease involving lipid deposition, inflammation, and fibrous elements.
• Vulnerable plaques, a progression of early fatty streaks, pose significant clinical risks.
• Mechanisms driving plaque instability from a stable state remain largely unknown.

Purpose of the Study:

• To investigate the role of the renin-angiotensin system (RAS) and angiotensin II in atherosclerosis development.
• To explore the potential contribution of angiotensin II to plaque vulnerability and progression.
• To elucidate the direct effects of angiotensin II beyond blood pressure regulation in atherosclerosis.

Main Methods:

• Review of epidemiologic, experimental, and clinical studies on RAS and atherosclerosis.
• Analysis of recent research on angiotensin II's role in plaque instability.
• Examination of direct cellular and molecular mechanisms involved.

Main Results:

• Epidemiologic, experimental, and clinical data support the RAS's contribution to atherosclerosis.
• Angiotensin II, the active peptide of RAS, influences atherosclerosis development and progression.
• Emerging evidence suggests angiotensin II acts as a mediator of plaque vulnerability.

Conclusions:

• The renin-angiotensin system, particularly angiotensin II, plays a multifaceted role in atherosclerosis.
• Angiotensin II contributes directly to disease progression and plaque vulnerability.
• Further research into RAS modulation may offer therapeutic strategies for atherosclerosis.